Has David Thomason, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,327 in general payments to David Thomason, MD across 454 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Thomason, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Thomason, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Thomason, MD

Physical Medicine & Rehabilitation · Daphne, ALNPI 1770878373

Payments from drug & device makers

$7,327in general payments, 2019–2025

Across 454 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$845
Arbor Pharmaceuticals, Inc.$406
UCB, Inc.$291
Teva Pharmaceuticals USA, Inc.$264
Scilex Pharmaceuticals Inc.$256
plus $3K from 49 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	119	$1,841
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	73	$845
Arbor Pharmaceuticals, Inc.	29	$406
UCB, Inc.	13	$291
Teva Pharmaceuticals USA, Inc.	14	$264
Scilex Pharmaceuticals Inc.	14	$256
Adamas Pharmaceuticals, Inc.	11	$232
Lilly USA, LLC	19	$208
SK Life Science, Inc.	8	$201
Tanabe Pharma America, Inc.	11	$179
Merz Pharmaceuticals, LLC	6	$164
Amgen	9	$156
Lundbeck LLC	7	$146
Pacira Therapeutics, Inc.	8	$145
Sunovion Pharmaceuticals Inc.	9	$133
Collegium Pharmaceutical, Inc.	8	$130
Valinor Pharma, LLC	8	$121
Azurity Pharmaceuticals, Inc.	7	$103
Zyla Life Sciences, Inc.	7	$103
Argenx US, Inc.	3	$93
AstraZeneca(2 entities)	5	$92
Nevro Corp.	3	$86
Novartis	4	$74
Bioventus LLC	3	$64
Abbott	3	$62
Biodelivery Sciences International, Inc.	4	$57
Averitas Pharma Inc.	3	$55
Neurelis, Inc.	3	$49
Grifols USA, LLC	2	$47
Alnylam Pharmaceuticals Inc.	2	$45
Globus Medical	2	$44
Medtronic	3	$42
Biogen	3	$40
Avanos Medical	1	$39
Biohaven Pharmaceuticals, Inc.	1	$39
Biotronik NRO, Inc.	2	$38
Tersera Therapeutics LLC	2	$37
Vertex	2	$36
Johnson & Johnson(2 entities)	2	$36
Acadia Pharmaceuticals Inc	2	$30
Biohaven Pharmaceutical Holding Company Ltd.	2	$29
Vertical Pharmaceuticals, LLC	2	$27
Upsher-smith Laboratories LLC	2	$26
Relievant Medsystems, Inc.	1	$25
Takeda Pharmaceuticals U.S.A., Inc.	1	$23
Pfizer	2	$23
Merz North America, Inc.	1	$20
Stryker	1	$20
Curonix LLC	1	$19
IBSA Pharma Inc.	1	$18
Siemens Medical Solutions USA, Inc.	1	$17
Tonix Medicines, Inc.	1	$14
Avanir Pharmaceuticals, Inc.	1	$12
GRT US Holding, Inc.	1	$12
Flowonix Medical Incorporated	1	$11

How this compares

$7,327 in reported general payments places this provider in the 90th percentile of 104 physical medicine & rehabilitation providers in Alabama.

See all physical medicine & rehabilitation providers in Alabama →

Medicare billing

Part B allowed, 2024

$670,778

Medicare patients

919

Services billed

53,819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Daphne

Jonathan RainerDaphne$4K
Fairen Walker-MccarterDaphne$980
Bradly GoodmanBirmingham$807K
Xiaohua ZhouBirmingham$221K
Charles HallMobile$167K
Vu NguyenBirmingham$71K
Don McCormickBirmingham$22K
Nelson Santos AgostoBirmingham$14K
John PantuoscoBirmingham$12K
Ross LumsdenBirmingham$11K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →